Clinical Trials

NCT02514226 | COMPLETED | NA

30 participants

Evaluation of Periodontal Treatment in Patients With Bronchiectasis

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2016-08-31

Completion:

2021-07-31

Conditions

• Bronchiectasis
• Periodontal Disease

Interventions

• PROCEDURE
• OTHER

No Results Yet

NCT02486718 | ACTIVE_NOT_RECRUITING | PHASE3

1280 participants

Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2015-10-31

Completion:

2024-01-26

Conditions

• Non-Small Cell Lung Cancer

Interventions

• DRUG

Results Available

NCT02482493 | SUSPENDED | NA

88 participants

All Polyethylene Versus Metal Backed Tibial Components in Knee Replacement

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2017-01-31

Completion:

2027-07-31

Conditions

• Osteoarthritis, Knee

Interventions

• DEVICE

No Results Yet

NCT02472795 | COMPLETED | PHASE1/PHASE2

105 participants

Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus Erythematosus

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2015-06-01

Completion:

2017-01-23

Conditions

• Systemic Lupus Erythematosus

Interventions

• DRUG

Results Available

NCT02447874 | RECRUITING | PHASE1/PHASE2

21 participants

Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2015-05-31

Completion:

2028-01-31

Conditions

• Sickle Cell Disease

Interventions

• DRUG

No Results Yet

NCT02316314 | RECRUITING

100 participants

Characterization of the Cardiac Phenotype of Friedreich's Ataxia (FRDA)

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-29

Start Date:

2015-01-15

Completion:

2027-08-31

Conditions

• Friedreich's Ataxia

Interventions

• PROCEDURE

No Results Yet

NCT02306161 | ACTIVE_NOT_RECRUITING | PHASE3

312 participants

Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2014-12-12

Completion:

2021-03-31

Conditions

• Metastatic Ewing Sarcoma
• Metastatic Malignant Neoplasm in the Bone
• Metastatic Malignant Neoplasm in the Bone Marrow
• Metastatic Malignant Neoplasm in the Lung
• Metastatic Peripheral Primitive Neuroectodermal Tumor of Bone
• Peripheral Primitive Neuroectodermal Tumor of Soft Tissues

Interventions

• DRUG
• RADIATION
• BIOLOGICAL
• PROCEDURE

Results Available

NCT02191488 | ACTIVE_NOT_RECRUITING | PHASE1

540 participants

ALA-induced PpIX Fluorescence During Brain Tumor Resection

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2014-07-31

Completion:

2027-12-31

Conditions

• Brain Tumors

Interventions

• DRUG

No Results Yet

NCT02178163 | ACTIVE_NOT_RECRUITING | NA

619 participants

Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2014-08-01

Completion:

2027-07-31

Conditions

• Recurrent Non-small Cell Lung Cancer
• Stage IV Non-small Cell Lung Cancer

Interventions

• OTHER

No Results Yet

NCT02166463 | ACTIVE_NOT_RECRUITING | PHASE3

600 participants

Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2015-03-19

Completion:

2021-12-31

Conditions

• Ann Arbor Stage IIB Hodgkin Lymphoma
• Ann Arbor Stage IIIB Hodgkin Lymphoma
• Ann Arbor Stage IVA Hodgkin Lymphoma
• Ann Arbor Stage IVB Hodgkin Lymphoma
• Childhood Hodgkin Lymphoma
• Classic Hodgkin Lymphoma

Interventions

• BIOLOGICAL
• DRUG
• OTHER

Results Available

NCT02142803 | ACTIVE_NOT_RECRUITING | PHASE1

50 participants

TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2014-05-20

Completion:

2020-12-31

Conditions

• Adult Glioblastoma
• Endometrial Clear Cell Adenocarcinoma
• Endometrial Serous Adenocarcinoma
• Ovarian Clear Cell Cystadenocarcinoma
• Ovarian Endometrioid Adenocarcinoma
• Ovarian Mucinous Cystadenocarcinoma
• Ovarian Serous Cystadenocarcinoma
• Recurrent Fallopian Tube Carcinoma
• Recurrent Malignant Uterine Corpus Neoplasm
• Recurrent Ovarian Carcinoma
• Recurrent Primary Peritoneal Carcinoma
• Solid Neoplasm
• Stage IIIA Fallopian Tube Cancer AJCC v7
• Stage IIIA Ovarian Cancer AJCC v6 and v7
• Stage IIIA Primary Peritoneal Cancer AJCC v7
• Stage IIIB Fallopian Tube Cancer AJCC v7
• Stage IIIB Ovarian Cancer AJCC v6 and v7
• Stage IIIB Primary Peritoneal Cancer AJCC v7
• Stage IIIC Fallopian Tube Cancer AJCC v7
• Stage IIIC Ovarian Cancer AJCC v6 and v7
• Stage IIIC Primary Peritoneal Cancer AJCC v7
• Stage IV Fallopian Tube Cancer AJCC v6 and v7
• Stage IV Ovarian Cancer AJCC v6 and v7
• Stage IV Primary Peritoneal Cancer AJCC v7

Interventions

• BIOLOGICAL
• OTHER
• DRUG

Results Available

NCT02112916 | ACTIVE_NOT_RECRUITING | PHASE3

847 participants

Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2014-10-04

Completion:

2020-03-31

Conditions

• Adult T Acute Lymphoblastic Leukemia
• Ann Arbor Stage II Adult Lymphoblastic Lymphoma
• Ann Arbor Stage II Childhood Lymphoblastic Lymphoma
• Ann Arbor Stage III Adult Lymphoblastic Lymphoma
• Ann Arbor Stage III Childhood Lymphoblastic Lymphoma
• Ann Arbor Stage IV Adult Lymphoblastic Lymphoma
• Ann Arbor Stage IV Childhood Lymphoblastic Lymphoma
• Childhood T Acute Lymphoblastic Leukemia

Interventions

• DRUG
• RADIATION

Results Available

NCT02101853 | ACTIVE_NOT_RECRUITING | PHASE3

669 participants

Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2014-12-17

Completion:

2021-06-30

Conditions

• Recurrent B Acute Lymphoblastic Leukemia

Interventions

• RADIATION
• DRUG
• OTHER
• PROCEDURE
• BIOLOGICAL

Results Available

NCT02029001 | RECRUITING | PHASE2

900 participants

Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatment

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2014-03-31

Completion:

2028-01-31

Conditions

• Malignant Solid Neoplasms

Interventions

• DRUG
• COMBINATION_PRODUCT

No Results Yet

NCT01984151 | WITHHELD

[Trial of device that is not approved or cleared by the U.S. FDA]

Last Updated:

2026-07-29

No Results Yet

NCT01874353 | ACTIVE_NOT_RECRUITING | PHASE3

327 participants

Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2013-09-03

Completion:

2016-09-19

Conditions

• Platinum Sensitive
• BRCA Mutated
• Relapsed Ovarian Cancer
• Following Complete or Partial Response to Platinum Based Chemotherapy

Interventions

• DRUG

Results Available

NCT01587352 | ACTIVE_NOT_RECRUITING | PHASE2

40 participants

Vorinostat in Treating Patients With Metastatic Melanoma of the Eye

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2012-05-29

Completion:

2026-12-31

Conditions

• Metastatic Uveal Melanoma
• Stage IV Uveal Melanoma AJCC v7

Interventions

• OTHER
• DRUG

No Results Yet

NCT01572506 | COMPLETED | PHASE1

58 participants

Mechanisms Accounting for Unexplained Anemia in the Elderly

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2012-03-29

Completion:

2015-07-30

Conditions

• Anemia

Interventions

• DRUG

No Results Yet

NCT01542021 | COMPLETED | NA

41 participants

Androgen Deprivation Therapy Prior to Prostatectomy for Patients With Intermediate and High Risk Prostate Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2012-02-24

Completion:

2024-09-30

Conditions

• Prostate Cancer
• Prostatic Adenocarcinoma

Interventions

• DRUG

Results Available

NCT01468896 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2

23 participants

Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That is Recurrent, Metastatic, or Cannot Be Removed by Surgery

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2011-10-26

Completion:

2015-09-29

Conditions

• Metastatic Head and Neck Squamous Cell Carcinoma
• Recurrent Head and Neck Squamous Cell Carcinoma
• Unresectable Head and Neck Squamous Cell Carcinoma

Interventions

• BIOLOGICAL
• OTHER

Results Available

NCT01458834 | COMPLETED | NA

60 participants

Attentional Training for Smoking Cessation Via Handheld Device or Personal Computer

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2011-09-30

Completion:

2012-12-31

Conditions

• Smoking

Interventions

• BEHAVIORAL

No Results Yet

NCT01269190 | RECRUITING | NA

275 participants

Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing Surgery

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2010-12-30

Completion:

2028-12-31

Conditions

• Oral Cavity Neoplasm

Interventions

• PROCEDURE
• DRUG

No Results Yet

NCT01262404 | COMPLETED

58 participants

Imaging Cerebral and Sub-cerebral Correlates of Meditative States

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-29

Start Date:

2010-01-31

Completion:

2011-10-31

Conditions

• Stress

No Results Yet

NCT01025089 | ACTIVE_NOT_RECRUITING | PHASE2

18 participants

Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2009-12-31

Completion:

2026-12-31

Conditions

• Thymoma
• Thymic Carcinoma
• Clinical Masaoka Stage II to IVA

Interventions

• DRUG

No Results Yet

NCT00972478 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2

83 participants

Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2010-11-15

Completion:

2015-12-30

Conditions

• Ann Arbor Stage II Non-Hodgkin Lymphoma
• Ann Arbor Stage III Non-Hodgkin Lymphoma
• Ann Arbor Stage IV Non-Hodgkin Lymphoma

Interventions

• DRUG
• OTHER
• BIOLOGICAL

Results Available

NCT00867464 | ACTIVE_NOT_RECRUITING

8670 participants

Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-29

Start Date:

2009-03-30

Completion:

2026-12-23

Conditions

• Anal Carcinoma
• Cervical Carcinoma
• Human Papillomavirus Infection
• Human Papillomavirus-Related Cervical Carcinoma
• Oral Cavity Carcinoma

Interventions

• OTHER

No Results Yet

NCT00644228 | ACTIVE_NOT_RECRUITING | PHASE3

525 participants

Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2008-07-28

Completion:

2015-11-05

Conditions

• DS Stage I Multiple Myeloma
• DS Stage II Multiple Myeloma
• DS Stage III Multiple Myeloma

Interventions

• DRUG
• OTHER

Results Available

NCT00593840 | ACTIVE_NOT_RECRUITING | PHASE2

74 participants

Phase II Trial Evaluating Elimination of Radiation Therapy

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2007-04-11

Completion:

2014-02-28

Conditions

• Cancer of the Larynx

Interventions

• RADIATION

Results Available

NCT00569127 | ACTIVE_NOT_RECRUITING | PHASE3

427 participants

Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2007-12-01

Completion:

2015-01-01

Conditions

• Colorectal Neuroendocrine Tumor G1
• Gastric Neuroendocrine Tumor G1
• Neuroendocrine Neoplasm
• Neuroendocrine Tumor
• Neuroendocrine Tumor G2

Interventions

• BIOLOGICAL
• OTHER
• DRUG

Results Available

NCT00556530 | RECRUITING

1000 participants

Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-29

Start Date:

2016-07-31

Completion:

2029-06-30

Conditions

• DiGeorge Syndrome
• 22q11.2 Deletion Syndrome

No Results Yet

NCT00505245 | RECRUITING

6500 participants

New Assessment System in Measuring Symptom Distress in Cancer Patients

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-29

Start Date:

1999-04-13

Completion:

2031-04-30

Conditions

• Caregiver
• Health Care Provider
• Malignant Neoplasm
• Physician

Interventions

• OTHER

No Results Yet

NCT00505063 | COMPLETED | PHASE2

75 participants

Prospective Trial of Vaccine Responses in Childhood Cancer Survivors

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2007-07-10

Completion:

2025-06-11

Conditions

• Childhood Cancer
• Multiple Diseases

Interventions

• BIOLOGICAL

Results Available

NCT00458536 | COMPLETED | PHASE1/PHASE2

36 participants

Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2004-10-31

Completion:

2014-12-31

Conditions

• Renal Cancer

Interventions

• BIOLOGICAL
• DRUG

Results Available

NCT00341276 | COMPLETED

7705 participants

Esophageal Cancer Genetics Studies

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-29

Start Date:

1995-07-06

Completion:

2020-03-18

Conditions

• Esophageal Cancer
• Gastric (Cardia, Body) Cancer

No Results Yet

NCT07732439 | NOT_YET_RECRUITING

100 participants

An Ambispective Natural History Study in Myotonic Dystrophy Patients Linking Retrospective Data Captured From the DM-Scope Registry With a Prospective 24-month Follow-up Period

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-28

Start Date:

2026-08-03

Completion:

2029-09-30

Conditions

• Myotonic Dystrophy 1
• Myotonic Dystrophy 2

No Results Yet

NCT07732426 | RECRUITING | NA

30 participants

Effects of Semaglutide on Brain Dopamine Responses to Food Cues in Adults With Obesity and Food Addiction Tendencies

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-28

Start Date:

2026-07-15

Completion:

2028-02-29

Conditions

• Food Addiction Tendency
• Obesity
• Overweight

Interventions

• DRUG

No Results Yet

NCT07732413 | NOT_YET_RECRUITING | PHASE1

30 participants

Trial of NLG802 Indoximod Prodrug Plus Temozolomide for Patients With Progressive Pediatric Brain Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-28

Start Date:

2026-10-08

Completion:

2030-10-08

Conditions

• Progressive Pediatric Brain Cancer

Interventions

• DRUG

No Results Yet

NCT07732400 | NOT_YET_RECRUITING | PHASE1/PHASE2

56 participants

A Study of VV-14303 for the Treatment of Metabolic Dysfunction-associated Steatohepatitis (MASH)

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-28

Start Date:

2026-07-31

Completion:

2028-07-31

Conditions

• Metabolic Dysfunction-associated Steatohepatitis (MASH)

Interventions

• GENETIC

No Results Yet

NCT07732387 | NOT_YET_RECRUITING | PHASE1

30 participants

A Study to Assess the Safety, Tolerability and Pharmacokinetics of Viaca (Sildenafil + Cabergoline) Compared With Sildenafil and Cabergoline

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-28

Start Date:

2026-08-01

Completion:

2026-09-19

Conditions

• Erectile Dysfunctions
• Healthy Volunteer

Interventions

• DRUG

No Results Yet

NCT07732374 | RECRUITING | PHASE2

35 participants

Long-Term Outcomes Following HBOT

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-28

Start Date:

2026-06-18

Completion:

2027-06-18

Conditions

• Traumatic Brain Injury
• Post-Concussive Symptoms
• Post-Traumatic Stress Disorder

Interventions

• DRUG

No Results Yet